Search Medical Condition
Please enter condition
Please choose location from dropdown
 

Psychosis Clinical Trials

A listing of Psychosis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (1059) clinical trials

A research study is enrolling for those suffering from Mild to Cognitive Impairment due to Alzheimer's Disease.  

Phase

Participate in a clinical trial exploring memory loss at ActivMed Practices and Research, Inc. in Methuen, MA.  

Phase

People with Alzheimer ’s disease are asked to participate in a research study being conducted by New York University School of Medicine.  

Phase N/A

This is a multi-center, randomized, double-blind, placebo-controlled, parallel group 36 week multicenter Phase 2 study of two doses of an investigational medication in adults with mild to moderate Alzheimer's Disease (AD).  

Phase N/A

The TauRX study is investigating the efficacy and safety of an investigational drug on symptoms of cognitive decline in individuals with mild  Alzheimer's disease, compared to a placebo. The study drug is a tablet which is taken by mouth twice per day. The study will last approximately 8 months.  

Phase

The Trailblazer study is investigating the safety, tolerability, and efficacy of an investigational drug on symptoms of cognitive and functional decline in individuals with early Alzheimer's disease. The study drug is an infusion that will be administered once per week for 75 weeks. The study will last approximately two and ...

Phase

Are you starting to experience memory problems? Are slight memory problems affecting your ability to do regular activities? Has anyone noticed a change in your memory? Do you have a family history of Alzheimer’s Disease? If so, you may be experiencing the first signs of memory loss. You may qualify ...

Phase

The purpose of this study is to understand whether the drug, pimavanserin, improves symptoms of hallucinations and/or delusions experienced in people with dementia.

Phase

Clinical research study of an investigational drug that may help slow or stop memory loss in people with early stages of Alzheimer's disease.  

Phase